FMC Corporation Q1 2007 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2007. FMC Corporation is a diversified, global chemical company operating in three segments: Agricultural Products, Specialty Chemicals, and Industrial Chemicals. The company reported 38,289,969 shares of common stock outstanding as of the period end.
Key Financial Metrics
| Metric | Q1 2007 | Q1 2006 |
|---|---|---|
| Revenue | $674.1 million | $594.1 million |
| Net Income | $45.8 million | $37.7 million |
| Diluted EPS | $1.17 | $0.95 |
| Operating Cash Flow | ($52.3) million (Used) | ($16.5) million (Used) |
| Cash and Equivalents | $49.2 million | $184.1 million |
| Total Debt | $617.7 million | $629.7 million |
| Effective Tax Rate | 26.9% | 39.5% |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenue increased 13.5% year-over-year, driven by higher sales across all segments.
- Profitability: Net income rose 21.5% to $45.8 million. Income from continuing operations increased significantly due to higher segment operating profits and a lower effective tax rate (26.9% vs. 39.5% in 2006, the latter impacted by a non-deductible European Commission fine).
- Restructuring Charges: Charges decreased to $24.3 million in Q1 2007 from $31.1 million in Q1 2006. The 2007 charge was primarily a $22.5 million settlement with Solutia regarding the Astaris joint venture.
- Discontinued Operations: Losses from discontinued operations widened to $9.3 million (from $0.6 million) due to a $15.4 million charge for environmental liabilities and legal reserves, primarily at the Middleport site.
- Cash Position: Cash and cash equivalents declined significantly from $165.5 million to $49.2 million, driven by operating cash outflows, debt repayments, and share repurchases.
Guidance, Outlook, and Risks
- Shareholder Returns: On April 24, 2007, the Board authorized a new $250 million share repurchase program, replacing the previous $150 million program. Additionally, the quarterly dividend was increased by 17% from $0.18 to $0.21 per share, effective July 2007.
- Segment Outlook:
- Agricultural Products: Full-year revenue growth expected at ~10%; operating profits up 20-25%.
- Specialty Chemicals: Full-year revenue growth expected at ~10%; operating profits up 10-15%.
- Industrial Chemicals: Full-year revenue growth expected in low-teens; operating profits expected to be level with the prior year due to higher energy costs.
- Legal and Environmental Risks:
- Solutia Settlement: A $22.5 million settlement was reached regarding the Astaris joint venture litigation.
- European Commission Fine: A €25 million fine (approx. $30 million) for hydrogen peroxide antitrust violations remains under appeal; interest accrues at 4.1%.
- Environmental Reserves: Total reserves stand at $174.7 million. Management estimates reasonably possible contingent losses may exceed accrued amounts by up to $70 million.
- Regulatory: Ongoing regulatory reviews for carbofuran in the U.S. and EU, with FMC challenging recent decisions.
Investor Verification Checklist
- Verify the impact of the $22.5 million Solutia settlement on future legal contingencies and the status of the appeal regarding the European Commission fine.
- Monitor the cash burn rate given the significant drop in cash equivalents ($116.3 million decrease) and the new $250 million repurchase authorization.
- Assess the regulatory risk to the Agricultural Products segment regarding the EPA and EU decisions on carbofuran, carbosulfan, and cadusafos.
- Review the environmental reserve adequacy, noting the $70 million potential exposure above current accruals and the $9.3 million loss from discontinued operations.
- Confirm the sustainability of Industrial Chemicals margins amidst rising energy costs and lower electricity selling prices in Spain.